Welcome to our dedicated page for Predictmedix news (Ticker: PMEDF), a resource for investors and traders seeking the latest updates and insights on Predictmedix stock.
Predictmedix Inc. (PMEDF) delivers AI-driven health screening solutions for global safety challenges. This page provides investors and stakeholders with official news updates on technological advancements, strategic partnerships, and operational developments.
Access real-time updates on AI health screening innovations, including deployments in healthcare, aviation, and government sectors. Track announcements related to Safe Entry Stations, regulatory milestones, and financial performance.
Users can expect verified updates on multispectral imaging breakthroughs, government contract awards, and expansion into new markets. All content is sourced directly from company filings and authorized communications.
Bookmark this page for streamlined access to Predictmedix's evolving role in non-invasive health monitoring technology. Check regularly for developments impacting public health infrastructure and workplace safety standards.
Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) has successfully cleared SEC comments on its Form 20-F registration statement, submitted on June 17, 2021. This registration allows Predictmedix to list equity securities on a U.S. national stock exchange, thus enhancing its reporting and transparency. It is now required to file regular reports with the SEC, providing investors with insights into its business strategies, risk factors, and financial performance. The company aims for further capital market activities to generate long-term value for its shareholders.
Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) has announced a strategic partnership with Entertainment Bay, a major event production company in India. This collaboration aims to deploy Safe Entry Stations at Entertainment Bay events, enhancing health screening for infectious diseases like COVID-19. With over 100 events managed annually, Predictmedix anticipates generating approximately $1,000 per unit per day. The partnership is expected to significantly expand Predictmedix's footprint in the Indian live event market, promoting safer event environments.
Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) announced its participation at the LD Micro Main Event investor conference from October 12-14, 2021, in Los Angeles, California. Chief Operating Officer Dr. Rahul Kushwah will present on October 12 at 2:00 p.m. Eastern time and will engage in one-on-one investor meetings. The company specializes in rapid health screening solutions using AI to identify health issues, including COVID-19 and substance impairments. A live audio webcast of the presentation will be available online.
Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) will present at the Benzinga Healthcare Small Cap Conference virtually on September 29, 2021. Dr. Rahul Kushwah, COO, will host a presentation at 11:10 a.m. Eastern time. The conference focuses on rapid health screening solutions using AI technology to detect health issues including COVID-19. Interested parties can access the presentation via this link.
Predictmedix offers AI-powered health screening and remote patient care services worldwide.
SBL Testing Technologies Inc. has partnered with Haztech Energy Corp and Haztech USA LLC to enhance the distribution of Predictmedix's SAFE ENTRY Station across North America. The partnership aims to leverage Haztech's extensive presence and client base to promote this innovative health screening technology.
SAFE ENTRY Stations utilize a proprietary AI algorithm to autonomously screen for infectious disease symptoms. This collaboration is positioned as a vital solution for managing COVID-19 exposure risks and future health challenges in workplaces and public venues.
Predictmedix Inc. announced a strategic partnership with Paras TechCare to manufacture and sell its Safe Entry Stations across the Southern Asian market. This collaboration leverages Paras' extensive public sector relationships, enhancing Predictmedix's presence in India. Initial installations are set at prominent events like the 2021 Most Influential Personalities event and the Forevermark Forum, aiming to raise commercial awareness. The partnership aims to utilize Paras' engineering expertise to improve production efficiency and reduce costs while providing advanced health screening solutions.
Predictmedix Inc. (CSE: PMED, OTCQB: PMEDF) deployed four Safe Entry Stations at the Palm Tree Music Festival on August 29, 2021, in Westhampton Beach, NY. This initiative, in partnership with JUICEWORKS and Northwell Health, aims to showcase the Company’s AI-enabled health screening solutions to government agencies and event organizers. Attendees will undergo symptom screening upon arrival, enhancing safety at the festival. Predictmedix is positioning itself as a key player in rapid health screening for large events globally.
Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) announces a strategic partnership with MZ Group to enhance its investor relations and financial communications. This collaboration aims to boost the company's visibility in capital markets and promote its AI-driven health screening solutions that detect various health issues, including COVID-19 and substance impairments. Notable clients include Indian Oil, which employs over 33,000 individuals. MZ Group, known for its extensive network, will support Predictmedix in achieving profitability and expanding its market presence.
Predictmedix Inc. (OTCQB: PMEDF) has filed a registration statement on Form 20-F with the SEC, aiming to register its common shares. This step will enable the Company to operate as a reporting issuer under U.S. securities laws. Predictmedix focuses on developing AI technologies for health and safety, including real-time screening for COVID-19 symptoms, alcohol impairment, and mental health conditions. This move broadens its potential market presence in the U.S.
